,Code_Description,DiseaseGroup,CodeType,TABLETYP,ICD9
B211,HIV disease resulting in Burkitt lymphoma,Cancer undergoing active chemo/radiotherapy,ICD-10,,
B238,HIV disease resulting in other specified conditions,Cancer undergoing active chemo/radiotherapy,ICD-10,A,042
C000,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1400
C001,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1401
C002,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1409
C003,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1403
C004,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1404
C005,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1405
C006,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1406
C008,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1408
C009,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1409
C01,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1410
C020,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1411
C021,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1412
C022,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1413
C023,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1414
C024,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1416
C028,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1418
C029,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1419
C030,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1430
C031,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1431
C039,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1439
C040,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1440
C041,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1441
C048,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1448
C049,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1449
C050,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1452
C051,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1453
C052,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1454
C058,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1458
C059,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1455
C060,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1450
C061,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1451
C062,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1456
C068,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1458
C069,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1459
C07,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1420
C080,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1421
C081,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1422
C088,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1428
C089,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1429
C090,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1461
C091,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1462
C098,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1468
C099,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1460
C100,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1463
C101,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1464
C102,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1466
C103,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1467
C104,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1468
C108,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1468
C109,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1469
C110,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1470
C111,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1471
C112,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1472
C113,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1473
C118,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1478
C119,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1479
C12,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1481
C130,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1480
C131,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1482
C132,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1483
C138,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1488
C139,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1489
C140,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1490
C142,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1491
C148,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1498
C150,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1500
C151,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1501
C152,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1502
C153,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1503
C154,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1504
C155,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1505
C158,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1508
C159,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1509
C160,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1510
C161,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1513
C162,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1514
C163,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1512
C164,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1511
C165,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1515
C166,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1516
C168,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1518
C169,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1519
C170,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1520
C171,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1521
C172,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1522
C173,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1523
C178,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1528
C179,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1529
C180,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1534
C181,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1535
C182,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1536
C183,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1530
C184,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1531
C185,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1537
C186,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1532
C187,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1533
C188,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1538
C189,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1539
C19,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1540
C20,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1541
C210,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1543
C211,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1542
C212,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1548
C218,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1548
C220,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1550
C221,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1551
C222,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1550
C223,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1550
C224,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1550
C227,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1550
C229,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1550
C23,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1560
C240,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1561
C241,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1562
C248,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1568
C249,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1569
C250,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1570
C251,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1571
C252,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1572
C253,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1573
C254,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1574
C257,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1578
C258,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1578
C259,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1579
C260,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1590
C261,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1591
C268,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1598
C269,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1599
C300,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1600
C301,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1601
C310,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1602
C311,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1603
C312,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1604
C313,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1605
C318,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1608
C319,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1609
C320,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1610
C321,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1611
C322,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1612
C323,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1613
C328,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1618
C329,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1619
C33,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1620
C340,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1622
C341,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1623
C342,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1624
C343,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1625
C348,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1628
C349,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1629
C37,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1640
C380,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1641
C381,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1642
C382,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1643
C383,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1649
C384,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1639
C388,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1648
C390,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1650
C398,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1658
C399,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1659
C400,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1704
C401,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1705
C402,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1707
C403,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1708
C408,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1709
C409,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1709
C411,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1701
C412,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1702
C413,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1703
C414,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1706
C418,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1709
C419,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1709
C430,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1720
C431,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1721
C432,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1722
C433,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1723
C434,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1724
C435,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1725
C436,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1726
C437,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1727
C438,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1728
C439,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1729
C440,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1730
C441,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1731
C442,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1732
C443,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1733
C444,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1734
C445,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1735
C446,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1736
C447,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1737
C448,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1738
C449,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1739
C450,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1639
C451,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1589
C452,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1641
C457,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1718
C459,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1719
C460,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1760
C461,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1761
C462,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1762
C463,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1765
C467,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1768
C468,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1768
C469,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1769
C470,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1710
C471,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1712
C472,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1713
C473,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1714
C474,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1715
C475,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1716
C476,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1717
C478,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1718
C479,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1719
C480,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1580
C481,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1588
C482,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1589
C488,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1588
C490,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1710
C491,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1712
C492,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1713
C493,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1714
C494,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1715
C495,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1716
C496,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1717
C498,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1718
C499,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1719
C500,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1740
C501,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1741
C502,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1742
C503,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1743
C504,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1744
C505,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1745
C506,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1746
C508,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1748
C509,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1749
C510,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1841
C511,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1842
C512,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1843
C518,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1848
C519,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1844
C52,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1840
C530,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1800
C531,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1801
C538,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1808
C539,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1809
C540,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1821
C541,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1820
C542,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1820
C543,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1820
C548,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1828
C549,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1820
C55,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,179
C56,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1830
C570,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1832
C571,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1833
C572,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1835
C573,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1834
C574,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1839
C577,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1848
C578,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1848
C579,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1849
C58,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,181
C600,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1871
C601,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1872
C602,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1873
C608,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1878
C609,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1874
C61,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,185
C620,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1860
C621,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1869
C629,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1869
C630,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1875
C631,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1876
C632,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1877
C637,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1878
C638,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1878
C639,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1879
C64,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1890
C65,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1891
C66,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1892
C670,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1880
C671,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1881
C672,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1882
C673,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1883
C674,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1884
C675,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1885
C676,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1886
C677,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1887
C678,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1888
C679,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1889
C680,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1893
C681,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1894
C688,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1898
C689,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1899
C690,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1903
C691,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1904
C692,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1905
C693,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1906
C694,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1900
C695,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1902
C696,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1901
C698,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1908
C699,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1909
C700,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1921
C701,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1923
C709,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1921
C710,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1910
C711,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1911
C712,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1912
C713,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1913
C714,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1914
C715,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1915
C716,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1916
C717,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1917
C718,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1918
C719,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1919
C720,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1922
C721,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1922
C722,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1920
C723,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1920
C724,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1920
C725,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1920
C728,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1928
C729,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1929
C73,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,193
C740,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1940
C741,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1940
C749,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1940
C750,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1941
C751,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1943
C752,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1943
C753,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1944
C754,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1945
C755,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1946
C758,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1948
C759,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1949
C760,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1950
C761,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1951
C762,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1952
C763,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1953
C764,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1954
C765,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1955
C767,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1958
C768,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1958
C770,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1960
C771,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1961
C772,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1962
C773,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1963
C774,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1965
C775,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1966
C778,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1968
C779,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1969
C780,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1970
C780,Secondary neoplasm lung,Cancer undergoing active chemo/radiotherapy,ICD-10,A,1970
C781,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1971
C782,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1972
C783,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1973
C784,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1974
C785,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1975
C786,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1976
C787,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1977
C788,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1978
C790,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1980
C791,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1981
C792,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1982
C793,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1983
C794,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1984
C795,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1985
C796,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1986
C797,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1987
C80,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10,A,1991
C810,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20140
C811,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20150
C812,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20160
C813,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20170
C817,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20100
C819,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20190
C820,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20200
C821,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20200
C822,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20000
C827,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20200
C829,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20200
C830,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20010
C831,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20010
C832,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20080
C833,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20000
C834,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20080
C835,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20280
C836,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20020
C837,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20020
C838,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20280
C839,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20280
C840,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20210
C841,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20220
C842,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20080
C843,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20080
C844,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20280
C845,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20280
C850,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20010
C851,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20280
C857,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20230
C859,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20280
C8800,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,2733
C8801,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,2733
C8810,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,2732
C8811,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,2732
C8820,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,2732
C8821,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,2732
C8830,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20380
C8831,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20381
C8870,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20380
C8871,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20381
C8890,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20380
C8891,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20381
C9000,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20300
C9001,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20301
C9010,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20310
C9011,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20311
C9020,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,2386
C9021,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,2386
C9100,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20400
C9101,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20401
C9110,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20410
C9111,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20411
C9120,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20420
C9121,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20421
C9130,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20490
C9131,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20491
C9140,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20240
C9141,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20241
C9150,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20890
C9151,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20891
C9170,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20480
C9171,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20481
C9190,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20490
C9191,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20491
C9200,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20500
C9201,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20501
C9210,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20510
C9211,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20511
C9220,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20520
C9221,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20521
C9230,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20530
C9231,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20531
C9240,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20500
C9241,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20501
C9250,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20500
C9251,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20501
C9270,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20580
C9271,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20581
C9290,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20590
C9291,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20591
C9300,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20600
C9301,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20601
C9310,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20610
C9311,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20611
C9320,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20620
C9321,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20621
C9370,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20680
C9371,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20681
C9390,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20690
C9391,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20691
C9400,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20700
C9401,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20701
C9410,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20710
C9411,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20711
C9420,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20720
C9421,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20721
C9430,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20780
C9431,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20781
C9440,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,2387
C9441,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,2387
C9450,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,2898
C9451,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20721
C9470,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20780
C9471,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20781
C9500,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20800
C9501,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20801
C9510,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20810
C9511,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20811
C9520,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20820
C9521,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20821
C9570,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20880
C9571,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20881
C9590,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20890
C9591,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20891
C960,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20250
C961,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20230
C962,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20260
C963,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20000
C965,Multifocal and unisystemic Langerhans-cell histiocytosis,Cancer undergoing active chemo/radiotherapy,ICD-10,,
C967,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20290
C969,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,20290
D097,Carcinoma in situ of other specified sites,Cancer undergoing active chemo/radiotherapy,ICD-10,A,2348
D374,Neoplasm of uncertain or unknown behaviour: Colon,Cancer undergoing active chemo/radiotherapy,ICD-10,A,2352
D377,Neoplasm of uncertain or unknown behaviour: Other digestive organs,Cancer undergoing active chemo/radiotherapy,ICD-10,A,2355
D470,Histiocytic and mast cell tumours of uncertain and unknown behaviour,Haematological Cancers,ICD-10,A,2385
D475,Chronic eosinophilic leukaemia [hypereosinophilic syndrome],Haematological Cancers,ICD-10,,
D477,"Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10,A,2387
D479,"Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified",Haematological Cancers,ICD-10,A,2387
D570,Sickle-cell anaemia with crisis,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,28262
D571,Sickle-cell anaemia without crisis,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,28261
D572,Double heterozygous sickling disorders,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,28263
D595,Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli],Haematological Cancers,ICD-10,A,2832
D70,Agranulocytosis,Cancer undergoing active chemo/radiotherapy,ICD-10,A,2880
D71X,Functional disorders of polymorphonuclear neutrophils,Haematological Cancers,ICD-10,,
D730,Hyposplenism,Haematological Cancers,ICD-10,A,28959
D760,"Langerhans' cell histiocytosis, not elsewhere classified",Haematological Cancers,ICD-10,A,2778
D761,Haemophagocytic lymphohistiocytosis,Haematological Cancers,ICD-10,A,2778
D800,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27904
D801,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27900
D802,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27901
D803,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27903
D804,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27902
D805,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27905
D806,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27909
D807,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27909
D808,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27909
D809,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27909
D810,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2792
D811,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2792
D812,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2792
D813,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2772
D814,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27913
D815,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2772
D816,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2792
D817,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2792
D818,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2792
D819,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2792
D820,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27912
D821,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27911
D822,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27919
D823,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27919
D824,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27919
D828,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2793
D829,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2793
D830,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27906
D831,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27906
D832,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27906
D838,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27906
D839,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27906
D840,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,27919
D841,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2798
D848,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2793
D849,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2793
D860,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,135
D861,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,135
D862,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,135
D863,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,135
D868,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,135
D869,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,135
D890,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2730
D891,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2732
D892,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2898
D898,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2798
D899,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2799
E703,Albinism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2702
E710,Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2703
E711,Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2703
E712,Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2703
E713,Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2724
E722,Disorders of urea cycle metabolism,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2706
E740,Glycogen storage disease,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2710
E752,Other sphingolipidosis ,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2727
E760,mucopolysaccharidoses,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2775
E761,mucopolysaccharidoses,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2775
E762,mucopolysaccharidoses,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2775
E763,mucopolysaccharidoses,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2775
E771,Defects in glycoprotein degradation,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,2718
E840,Cystic fibrosis,Respiratory,ICD-10,A,27700
E841,Cystic fibrosis,Respiratory,ICD-10,A,27701
E848,Cystic fibrosis,Respiratory,ICD-10,A,27700
E849,Cystic fibrosis,Respiratory,ICD-10,A,27700
G10X,Huntington disease,"Rare genetic, metabolic and autoimmune diseases",ICD-10,,
G113,Cerebellar ataxia with defective DNA repair,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,3343
G712,Congenital myopathies,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,3590
I270,Primary pulmonary hypertension,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,4160
I712,"Thoracic aortic aneurysm, without mention of rupture",Congenital Heart,ICD-10,A,4412
J410,Simple and mucopurulent chronic bronchitis,Respiratory,ICD-10,A,4910
J411,Simple and mucopurulent chronic bronchitis,Respiratory,ICD-10,A,4911
J418,Simple and mucopurulent chronic bronchitis,Respiratory,ICD-10,A,4918
J42,Unspecified chronic bronchitis,Respiratory,ICD-10,A,4919
J440,Other chronic obstructive pulmonary disease,Respiratory,ICD-10,A,49121
J441,Other chronic obstructive pulmonary disease,Respiratory,ICD-10,A,49121
J448,Other chronic obstructive pulmonary disease,Respiratory,ICD-10,A,496
J449,Other chronic obstructive pulmonary disease,Respiratory,ICD-10,A,496
J46X,Status asthmaticus,Respiratory,ICD-10,,
J47,Bronchiectasis,Respiratory,ICD-10,A,494
J61,Pneumoconiosis due to asbestos and other mineral fibres,Respiratory,ICD-10,A,501
J620,Pneumoconiosis due to talc dust,Respiratory,ICD-10,A,502
J630,Aluminosis (of lung),Respiratory,ICD-10,A,503
J631,Bauxite fibrosis (of lung),Respiratory,ICD-10,A,503
J633,Graphite fibrosis (of lung),Respiratory,ICD-10,A,503
J634,Siderosis,Respiratory,ICD-10,A,503
J635,Stannosis,Respiratory,ICD-10,A,503
J660,Byssinosis,Respiratory,ICD-10,A,504
J661,Flax-dresser disease,Respiratory,ICD-10,A,504
J662,Cannabinosis,Respiratory,ICD-10,A,504
J668,Airway disease due to other specific organic dusts,Respiratory,ICD-10,A,504
J670,Farmer lung,Respiratory,ICD-10,A,4950
J671,Bagassosis,Respiratory,ICD-10,A,4951
J678,Hypersensitivity pneumonitis due to other organic dusts,Respiratory,ICD-10,A,4958
J684,"Chronic respiratory conditions due to chemicals, gases, fumes and vapours",Respiratory,ICD-10,A,5064
J688,"Other respiratory conditions due to chemicals, gases, fumes and vapours",Respiratory,ICD-10,A,5064
J698,Pneumonitis due to other solids and liquids,Respiratory,ICD-10,A,5078
J701,Chronic and other pulmonary manifestations due to radiation,Respiratory,ICD-10,A,5081
J703,Chronic drug-induced interstitial lung disorders,Respiratory,ICD-10,A,5088
J840,Alveolar and parietoalveolar conditions,Respiratory,ICD-10,A,5160
J983,Compensatory emphysema,Respiratory,ICD-10,A,5182
J991,Respiratory disorders in other diffuse connective tissue disorders,Respiratory,ICD-10,A,5172
L412,Lymphomatoid papulosis,Haematological Cancers,ICD-10,A,6962
M312,Lethal midline granuloma,Cancer undergoing active chemo/radiotherapy,ICD-10,A,4463
M313,Wegener granulomatosis,Respiratory,ICD-10,A,4464
P250,Interstitial emphysema originating in the perinatal period,Respiratory,ICD-10,A,7702
P615,Transient neonatal neutropenia,Haematological Cancers,ICD-10,A,7767
Q200,Common arterial trunk,Congenital Heart,ICD-10,A,7450
Q203,Discordant ventriculoarterial connection,Congenital Heart,ICD-10,A,74510
Q204,Double inlet ventricle,Congenital Heart,ICD-10,A,7453
Q205,Discordant atrioventricular connection,Congenital Heart,ICD-10,A,74512
Q208,Other congenital malformations of cardiac chambers and connections,Congenital Heart,ICD-10,A,7458
Q211,Atrial septal defect,Congenital Heart,ICD-10,A,7455
Q212,Atrioventricular septal defect,Congenital Heart,ICD-10,A,74560
Q223,Other congenital malformations of pulmonary valve,Congenital Heart,ICD-10,A,74609
Q231,Congenital insufficiency of aortic valve,Congenital Heart,ICD-10,A,7464
Q238,Other congenital malformations of aortic and mitral valves,Congenital Heart,ICD-10,A,74689
Q245,Malformation of coronary vessels,Congenital Heart,ICD-10,A,74685
Q248,Other specified congenital malformations of heart,Congenital Heart,ICD-10,A,74689
Q254,Other congenital malformations of aorta,Congenital Heart,ICD-10,A,74729
Q268,Other congenital malformations of great veins,Congenital Heart,ICD-10,A,74749
Q288,Other specified congenital malformations of circulatory system,Congenital Heart,ICD-10,A,74789
Q334,Congenital bronchiectasis,Respiratory,ICD-10,A,74861
Q851,Tuberous sclerosis,"Rare genetic, metabolic and autoimmune diseases",ICD-10,A,7595
Q859,"Phakomatosis, unspecified","Rare genetic, metabolic and autoimmune diseases",ICD-10,A,7596
Q878,"Other specified congenital malformation syndromes, not elsewhere classified",Congenital Heart,ICD-10,A,75989
Q878,"Other specified congenital malformation syndromes, not elsewhere classified","Rare genetic, metabolic and autoimmune diseases",ICD-10,A,75989
Q893,Situs inversus,Congenital Heart,ICD-10,A,7593
Q898,Other specified congenital malformations,Congenital Heart,ICD-10,A,75989
T860,Bone-marrow transplant rejection,Transplant,ICD-10,B,99685
T861,Kidney transplant failure and rejection,Transplant,ICD-10,B,99681
T862,Heart transplant failure and rejection,Transplant,ICD-10,B,99683
T863,Heart-lung transplant failure and rejection,Transplant,ICD-10,B,99683
T864,Liver transplant failure and rejection,Transplant,ICD-10,B,99682
T8681,Failure and rejection of other transplanted organs and tissues,Transplant,ICD-10,B,99684
T8682,Failure and rejection of other transplanted organs and tissues,Transplant,ICD-10,B,99686
T8688,Failure and rejection of other transplanted organs and tissues,Transplant,ICD-10,B,99689
T869,Failure and rejection of unspecified transplanted organ and tissue,Transplant,ICD-10,B,99680
Z510,Radiotherapy session,Cancer undergoing active chemo/radiotherapy,ICD-10,V,V580
Z511,Chemotherapy session for neoplasm,Cancer undergoing active chemo/radiotherapy,ICD-10,V,V5811
Z940,Transplanted organ and tissue status,Transplant,ICD-10,V,V420
Z941,Transplanted organ and tissue status,Transplant,ICD-10,V,V421
Z942,Transplanted organ and tissue status,Transplant,ICD-10,V,V426
Z943,Transplanted organ and tissue status,Transplant,ICD-10,V,V426
Z944,Transplanted organ and tissue status,Transplant,ICD-10,V,V427
Z945,Transplanted organ and tissue status,Transplant,ICD-10,V,V423
Z946,Transplanted organ and tissue status,Transplant,ICD-10,V,V424
Z947,Transplanted organ and tissue status,Transplant,ICD-10,V,V425
Z948,Transplanted organ and tissue status,Transplant,ICD-10,V,V428
Z949,Transplanted organ and tissue status,Transplant,ICD-10,V,V429
